Rocket


News + Filings
Transactions



George Simeon

DateNameSymbolTypeSecuritySharesPriceValueOwnershipReported
06/08/2023CRISPR Therapeutics AGCRSPGrantStock Option (Right to Buy)13k$62.59$813.7k 06/08/2023
06/07/2023Nkarta, Inc.NKTXGrantStock Option (right to buy)22.5k$4.86$109.4k 06/07/2023
05/31/2023Design Therapeutics, Inc.DSGNGrantStock Option (right to buy)15k$5.63$84.4k 05/31/2023
12/20/2022Design Therapeutics, Inc.DSGNPurchaseCommon Stock40k$8.14$325.4kSee Note 212/16/2022
12/19/2022Design Therapeutics, Inc.DSGNPurchaseCommon Stock360k$8.63$3.1MSee Note 212/16/2022
12/16/2022Design Therapeutics, Inc.DSGNPurchaseCommon Stock500k$8.28$4.1MSee Note 212/16/2022
08/17/2022Turning Point Therapeutics, Inc.TPTXDispositionCommon Stock2.3M$76.00$171.3MSee Footnote08/17/2022
08/17/2022Turning Point Therapeutics, Inc.TPTXDispositionStock Option (right to buy)15k$27.06$405.9k 08/17/2022
08/17/2022Turning Point Therapeutics, Inc.TPTXDispositionStock Option (right to buy)8.5k$65.39$555.8k 08/17/2022
08/17/2022Turning Point Therapeutics, Inc.TPTXDispositionStock Option (right to buy)8.5k$65.64$557.9k 08/17/2022
06/15/2022Design Therapeutics, Inc.DSGNGrantStock Option (right to buy)15k$13.69$205.4k 06/15/2022
06/09/2022CRISPR Therapeutics AGCRSPGrantStock Option (Right to Buy)12k$71.70$860.4k 06/09/2022
06/08/2022Nkarta, Inc.NKTXGrantStock Option (right to buy)16k$14.95$239.2k 06/08/2022
04/28/2022Nkarta, Inc.NKTXPurchaseCommon Stock666.7k$15.00$10MSee Footnote04/28/2022
04/28/2022Nkarta, Inc.NKTXPurchaseCommon Stock666.7k$15.00$10MSee Footnote04/28/2022
06/13/2021Nkarta, Inc.NKTXGrantStock Option (right to buy)16.5k$25.03$413.3k 06/13/2021
06/10/2021CRISPR Therapeutics AGCRSPGrantStock Option (Right to Buy)10k$123.71$1.2M 06/10/2021
06/02/2021Turning Point Therapeutics, Inc.TPTXGrantStock Option (right to buy)8.5k$65.64$557.9k 06/02/2021
03/30/2021Design Therapeutics, Inc.DSGNConversionCommon Stock4.4M$0.00$0See footnote03/30/2021
03/30/2021Design Therapeutics, Inc.DSGNConversionCommon Stock936.6k$0.00$0See footnote03/30/2021
03/30/2021Design Therapeutics, Inc.DSGNConversionSeries A Preferred Stock7.2M$0.00$0See footnote03/30/2021
03/30/2021Design Therapeutics, Inc.DSGNConversionSeries B Preferred Stock1.5M$0.00$0See tootnote03/30/2021
03/30/2021Design Therapeutics, Inc.DSGNPurchaseCommon Stock250k$20.00$5MSee footnote03/30/2021
03/25/2021Design Therapeutics, Inc.DSGNGrantStock Option (right to buy)15k$20.00$300k 03/25/2021
09/28/2020Principia Biopharma Inc.PRNBDispositionWarrant28.6k$0.00$0See Footnote09/28/2020
09/28/2020Principia Biopharma Inc.PRNBDispositionDirector Stock Option (right to buy)20.5k$0.00$0 09/28/2020
09/28/2020Principia Biopharma Inc.PRNBDispositionDirector Stock Option (right to buy)10.2k$0.00$0 09/28/2020
09/28/2020Principia Biopharma Inc.PRNBOtherCommon Stock3M$100.00$298.3MSee Footnote09/28/2020
07/09/2020Nkarta, Inc.NKTXGrantStock Option (right to buy)10.7k$18.00$192.6k 07/09/2020
06/15/2020Turning Point Therapeutics, Inc.TPTXGrantStock Option (right to buy)8.5k$65.39$555.8k 06/15/2020
06/11/2020CRISPR Therapeutics AGCRSPGrantStock Option (Right to Buy)15k$59.70$895.5k 06/11/2020
06/04/2020Principia Biopharma Inc.PRNBGrantDirector Stock Option (right to buy)10.2k$62.66$641.6k 06/04/2020
05/21/2020Turning Point Therapeutics, Inc.TPTXPurchaseCommon Stock83.3k$60.00$5MSee Footnote05/21/2020
10/18/2019Principia Biopharma Inc.PRNBPurchaseCommon Stock357.1k$28.00$10MSee Footnote10/18/2019
09/10/2019Turning Point Therapeutics, Inc.TPTXPurchaseCommon Stock177.8k$45.00$8MSee Footnote09/10/2019
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy